首页> 外文期刊>Journal of paediatrics and child health >Perinatal outcomes of intrauterine insemination/clomiphene pregnancies represent an intermediate risk group compared with in vitro fertilisation/ intracytoplasmic sperm injection and naturally conceived pregnancies
【24h】

Perinatal outcomes of intrauterine insemination/clomiphene pregnancies represent an intermediate risk group compared with in vitro fertilisation/ intracytoplasmic sperm injection and naturally conceived pregnancies

机译:与体外受精/胞浆内精子注射和自然怀孕相比,宫内授精/克罗米芬妊娠的围产期结局是中等风险人群

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: To compare the pregnancy outcomes in terms of perinatal morbidities and mortality for different types of assisted reproductive technology (ART). Methods: A retrospective cohort study was conducted of all babies born by ART in Singapore General Hospital, between 1 November 2001 and 11 January 2012. Results: Incidence of ART was 3.5% in our birth cohort. Pregnancies conceived by ART were more likely to be multiple pregnancies OR 43.50, and were more likely to be premature OR 5.51. Mortality OR was 3.93. IVF/ICSI contributed to an increased OR for multiple gestation of 48.26, an increased OR for prematurity of 5.95 and increased OR for low birthweight of 5.54. Mortality OR was 4.33. Intrauterine insemination (IUI)/clomiphene may represent a lower risk group compared with in vitro fertilisation/intracytoplasmic sperm injection (IVF/ICSI). Prematurity OR was only 2.35, and low birthweight OR was 2.38. These were less than half of IVF/ICSI. Fewer neonatal morbidities were found. Mortality was insignificant. Multiplicity had significant impact on perinatal outcomes in ART and IVF/ICSI but not in IUI/clomiphene conceptions, demonstrated by singleton subgroup analyses and by logistic regression using prematurity as outcome. Conclusion: IUI/clomiphene represented an intermediate risk group compared with the IVF/ICSI.
机译:目的:比较围产期发病率和不同类型辅助生殖技术(ART)死亡率的妊娠结局。方法:在2001年11月1日至2012年1月11日期间,对新加坡综合医院ART所生的所有婴儿进行了回顾性队列研究。结果:在我们的出生队列中,ART的发生率为3.5%。 ART怀孕的可能性更大,可能是多次怀孕,即43.50,而早产的可能性更大,即5.51。死亡率或为3.93。 IVF / ICSI导致多胎妊娠的OR增加到48.26,早产OR升高了5.95,低出生体重OR升高了5.54。死亡率或为4.33。与体外受精/胞浆内精子注射(IVF / ICSI)相比,宫内授精(IUI)/克罗米芬可能代表了较低的风险人群。早产OR仅为2.35,低出生体重OR为2.38。这些不到IVF / ICSI的一半。发现较少的新生儿发病率。死亡率微不足道。多重性对ART和IVF / ICSI的围产期结局有显着影响,但对IUI /克罗米芬的概念影响不大,这通过单例亚组分析和以早产为结局的逻辑回归得到证明。结论:与IVF / ICSI相比,IUI /克罗米芬是一个中等风险组。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号